Loading clinical trials...
Loading clinical trials...
Predictive Value of In-vitro Testing Anti-cancer Therapy Sensitivity on Tumorspheres From Patients With Metastatic Colorectal Cancer
The purpose of the present study is to investigate the benefit of anti-cancer therapy administered on the basis of drug sensitivity testing. This concerns colorectal cancer patients who have previously received standard treatment.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Department of Oncology, Aalborg University Hospital
Aalborg, Denmark
Department of Oncology, Rigshospitalet
Copenhagen, Denmark
Departmen of Oncology, Vejle Hospital
Vejle, Denmark
Universitätsklinikum Hamburg - Eppendorf, Universitäres Cancer Center Hamburg (UCCH)
Hamburg, Germany
Start Date
September 22, 2017
Primary Completion Date
August 23, 2021
Completion Date
March 21, 2022
Last Updated
January 18, 2023
90
ACTUAL participants
Based on sensitivity analysis
DRUG
Lead Sponsor
Vejle Hospital
NCT05759728
NCT07328087
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07213570